TDAM USA’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $465K | Buy |
5,315
+53
| +1% | +$4.4K | 0.03% | 205 |
|
|
2021
Q3 | $430K | Hold |
5,262
| – | – | 0.03% | 204 |
|
|
2021
Q2 | $486K | Buy |
5,262
+34
| +0.7% | +$3.03K | 0.03% | 201 |
|
|
2021
Q1 | $447K | Sell |
5,228
-1,871
| -26% | -$168K | 0.03% | 218 |
|
|
2020
Q4 | $670K | Sell |
7,099
-6
| -0.1% | -$524 | 0.04% | 182 |
|
|
2020
Q3 | $618K | Sell |
7,105
-400
| -5% | -$34.7K | 0.04% | 176 |
|
|
2020
Q2 | $655K | Buy |
7,505
+100
| +1% | +$8.63K | 0.05% | 175 |
|
|
2020
Q1 | $611K | Sell |
7,405
-40
| -0.5% | -$3.57K | 0.05% | 180 |
|
|
2019
Q4 | $705K | Buy |
7,445
+2,582
| +53% | +$232K | 0.05% | 189 |
|
|
2019
Q3 | $423K | Buy |
4,863
+306
| +7% | +$27.5K | 0.03% | 205 |
|
|
2019
Q2 | $416K | Sell |
4,557
-103
| -2% | -$8.72K | 0.03% | 208 |
|
|
2019
Q1 | $401K | Buy |
4,660
+837
| +22% | +$67.2K | 0.03% | 206 |
|
|
2018
Q4 | $294K | Sell |
3,823
-1,086
| -22% | -$84.5K | 0.02% | 274 |
|
|
2018
Q3 | $360K | Hold |
4,909
| – | – | 0.02% | 277 |
|
|
2018
Q2 | $332K | Sell |
4,909
-2,320
| -32% | -$160K | 0.02% | 283 |
|
|
2018
Q1 | $524K | Sell |
7,229
-5,480
| -43% | -$417K | 0.03% | 247 |
|
|
2017
Q4 | $956K | Buy |
12,709
+501
| +4% | +$37.8K | 0.05% | 204 |
|
|
2017
Q3 | $939K | Sell |
12,208
-86,870
| -88% | -$6.56M | 0.06% | 205 |
|
|
2017
Q2 | $7.47M | Sell |
99,078
-235
| -0.2% | -$16.7K | 0.39% | 92 |
|
|
2017
Q1 | $6.61M | Buy |
99,313
+1,073
| +1% | +$71.5K | 0.33% | 92 |
|
|
2016
Q4 | $6.41M | Sell |
98,240
-5,034
| -5% | -$327K | 0.34% | 91 |
|
|
2016
Q3 | $7.31M | Buy |
103,274
+513
| +0.5% | +$37.4K | 0.36% | 89 |
|
|
2016
Q2 | $7.6M | Buy |
102,761
+2,241
| +2% | +$155K | 0.37% | 88 |
|
|
2016
Q1 | $6.53M | Sell |
100,520
-244
| -0.2% | -$16.6K | 0.32% | 95 |
|
|
2015
Q4 | $7.77M | Sell |
100,764
-11
| -0% | -$874 | 0.38% | 84 |
|
|
2015
Q3 | $8.3M | Sell |
100,775
-262
| -0.3% | -$23.3K | 0.42% | 76 |
|
|
2015
Q2 | $8.9M | Sell |
101,037
-619
| -0.6% | -$56.8K | 0.4% | 82 |
|
|
2015
Q1 | $8.98M | Sell |
101,656
-378
| -0.4% | -$33.5K | 0.37% | 89 |
|
|
2014
Q4 | $8.47M | Sell |
102,034
-356
| -0.3% | -$29.5K | 0.36% | 93 |
|
|
2014
Q3 | $8.64M | Buy |
102,390
+359
| +0.4% | +$29K | 0.37% | 92 |
|
|
2014
Q2 | $8.28M | Sell |
102,031
-1,580
| -2% | -$124K | 0.35% | 99 |
|
|
2014
Q1 | $7.89M | Sell |
103,611
-3,673
| -3% | -$268K | 0.34% | 101 |
|
|
2013
Q4 | $7.73M | Buy |
107,284
+91,047
| +561% | +$6.33M | 0.33% | 94 |
|
|
2013
Q3 | $1.12M | Sell |
16,237
-93,815
| -85% | -$6.21M | 0.05% | 135 |
|
|
2013
Q2 | $7.08M | Buy |
+110,052
| New | +$7.16M | 0.32% | 84 |
|
Other funds holding NVS
TDAM USA's NVS Position: Q4 2021 in Review
TDAM USA increased its Novartis (NVS) stake by 1% in Q4 2021, buying an estimated $4.4K and bringing the position to 5,315 shares worth $465K. The position accounts for 0.03% of the portfolio, ranked #205.
TDAM USA first reported a position in NVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $8.98M in Q1 2015. 1,147 funds tracked by Wall St. Rank hold NVS as of Q4 2021.
- TDAM USA held 5,315 shares of Novartis worth $465K as of Q4 2021.
- TDAM USA bought 53 Novartis shares in Q4 2021, an estimated $4.4K.
- Novartis made up 0.03% of TDAM USA's portfolio in Q4 2021, its #205 holding.
- TDAM USA first reported a position in Novartis in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's Novartis position peaked at $8.98M in Q1 2015.
- 1,147 funds tracked by Wall St. Rank held Novartis as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.